All Type of News
Court rules fine over ‘pay for delay’ to GSK is justifiable
An appeals court ruled Thursday that fines of 3.1 billion won was justifiable over “pay for delay” the Fair Trade Commission (FTC) imposed to GlaxoSmithKline (GSK).
Turning down an appeal from GSK, the Seoul High C...
New heat rate-lowing agent to be released in November
Servier Korea said yesterday that it will roll out Procoralan (ivabradine) here from November.
Procoralan is the first pure heart rate-lowering agent and acts by selective inhibition of the cardiac pacemaker If cu...
Celltrion to cut Remsima price by 50% for low-income households
Celltrion, a local biopharmaceutical company, said it will cut the insurance price of its antibody biosimilar product “Resima” by 50 percent for low-income patients who are not covered by the national health insurance...
Leading pharmaceutical firms continue to add subsidiariesThe business expansion of Korea’s major drug firms shows no sign of abating, with the number of their affiliated companies averaging 10, according to a report by Yakup.com, phar...
|
Will cancellation criteria of innovative pharmaceutical firms be discussed in upcoming parliamentary
All eyes are on the upcoming parliamentary interpellation session on October 24, during which the cancellation criteria of innovative pharmaceutical firms is likely to be a hot issue.
Investigators raided the headq...
Disagreement over issuance of 2 prescription sheets
Doctors are opposing the government’s plan to punish doctors who fail to issue two prescription sheets, which has been recently in the parliamentary audit session.
In a statement on Thursday, the Korea Medical Clin...
Green Cross making all-out efforts for management normalization of Innocell
Green Cross Corp., the largest shareholder of Innocell, a cell therapeutics company, said in its regulatory filing Wednesday that it has decided to voluntarily restrict the selling of its equities over the next three ...
Measures urged over stable supply of rare drugs
A lawmaker on Wednesday called for proper steps to allow patients to have easier access to high-priced lifesaving drugs.
The government should work out measures to settle the time-consuming negotiations with pharma...
Lawmakers calls for transparent drug pricing negotiation
The current positive list system stipulates a strict screening process of new drugs eligible for national health insurance reimbursement. It aims to encourage pharmaceutical producers to come up with ways to offer eff...
Measures urged over ever-increasing medication expenses
Medication costs are a main cause of deficits in the state-run health insurance scheme.
A lawmaker on Tuesday called for steps to bring down spending on medicines.
Drug expenses made up over 35.3 percent of the ...
